ENTITY

Apellis Pharmaceuticals (APLS US)

36
Analysis
Health CareUnited States
Apellis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. Apellis Pharmaceuticals serves clients worldwide.
more
Company Event21 Feb 2025 22:30 • Upcoming
Add To Calendar
Company Event05 Nov 2024 21:30 • Latest
Company Event27 Oct 2024 03:30
Company Event08 Aug 2024 20:00
Company Event01 Aug 2024 20:30
x